Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |